ストックスクリーナーアプリを入手
21.12
0.18%
-0.055
前日終値:
$21.18
開ける：
$21.19
24時間の取引高:
2.55M
Relative Volume:
0.31
時価総額：
$14.69B
収益：
$125.68M
当期純損益:
$4.81B
株価収益率:
3.7381
EPS:
5.65
ネットキャッシュフロー:
$-781.21M
1週間 パフォーマンス:
+1.57%
1か月 パフォーマンス:
+4.48%
6か月 パフォーマンス:
+88.72%
1年 パフォーマンス:
+74.97%
1日の値動き範囲:
$20.84
$21.33
1週間の範囲:
$19.96
$21.33
52週間の値動き範囲:
$8.73
$21.35
Roivant Sciences Ltd Stock (ROIV) Company Profile
ROIV を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ROIV
Roivant Sciences Ltd
|
21.11 | 14.73B | 125.68M | 4.81B | -781.21M | 5.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.17 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
720.87 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.00 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
903.20 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.54 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Roivant Sciences Ltd Stock (ROIV) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-02 | 開始されました | Citigroup | Buy |
| 2025-07-10 | 再開されました | Goldman | Buy |
| 2024-02-15 | 開始されました | Wolfe Research | Outperform |
| 2024-01-05 | 開始されました | Piper Sandler | Overweight |
| 2023-12-12 | 開始されました | Deutsche Bank | Buy |
| 2023-10-17 | 開始されました | Guggenheim | Buy |
| 2023-06-08 | 開始されました | BofA Securities | Neutral |
| 2022-10-27 | 開始されました | JP Morgan | Overweight |
| 2022-05-23 | 開始されました | SVB Leerink | Outperform |
| 2022-04-29 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-12-15 | 開始されました | Goldman | Buy |
| 2021-11-08 | 開始されました | H.C. Wainwright | Buy |
| 2021-10-28 | 開始されました | Citigroup | Buy |
| 2021-10-26 | 開始されました | Cowen | Outperform |
| 2021-10-26 | 開始されました | Jefferies | Buy |
| 2021-10-26 | 開始されました | Truist | Buy |
すべてを表示
Roivant Sciences Ltd (ROIV) 最新ニュース
Roivant Sciences Ltd. $ROIV Position Increased by Two Seas Capital LP - MarketBeat
Roivant Sciences Ltd. $ROIV Shares Sold by Pertento Partners LLP - MarketBeat
Is Roivant Sciences Ltd. stock safe for conservative investors2025 Winners & Losers & Daily Profit Focused Screening - Newser
Is Roivant Sciences Ltd. (87S) stock safe for risk averse investorsJuly 2025 Fed Impact & High Yield Stock Recommendations - Newser
Why Roivant Sciences Ltd. stock could rally in 2025Dividend Hike & Weekly Breakout Watchlists - Newser
How Roivant Sciences Ltd. (87S) stock compares with market leadersJuly 2025 Trends & Community Verified Trade Signals - Newser
Is Roivant Sciences Ltd. (87S) stock undervalued by metricsWeekly Trend Recap & High Conviction Buy Zone Alerts - Newser
Will Roivant Sciences Ltd. stock recover faster than peers2025 Market Overview & Capital Efficiency Focused Strategies - Newser
How Roivant Sciences Ltd. (87S) stock trades after rate cutsM&A Rumor & High Win Rate Trade Tips - Newser
Roivant Sciences Ltd. (ROIV) Stock Forecasts - Yahoo Finance
Why analysts recommend Roivant Sciences Ltd. (87S) stockJuly 2025 Sector Moves & Consistent Profit Trade Alerts - Newser
Is Roivant Sciences Ltd. (87S) stock prepared for digital transitionWeekly Trend Summary & Fast Entry High Yield Stock Tips - Newser
Why Roivant Sciences Ltd. (87S) stock signals breakout potential2025 Dividend Review & Risk Managed Investment Strategies - Newser
Rhumbline Advisers Reduces Stock Holdings in Roivant Sciences Ltd. $ROIV - MarketBeat
Can Roivant Sciences Ltd. (87S) stock survive global slowdownJuly 2025 Reactions & Free Safe Capital Growth Stock Tips - Newser
Swiss National Bank Lowers Stake in Roivant Sciences Ltd. $ROIV - MarketBeat
Loomis Sayles & Co. L P Sells 352,443 Shares of Roivant Sciences Ltd. $ROIV - MarketBeat
Roivant Sciences (ROIV) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
(ROIV) Price Dynamics and Execution-Aware Positioning - news.stocktradersdaily.com
33,356 Shares in Roivant Sciences Ltd. $ROIV Acquired by Inceptionr LLC - MarketBeat
Immunovant, Roivant slip after trial data for autoimmune disorder therapy - MSN
Volume Report: Why Roivant Sciences Ltd. stock could be next big winnerEarnings Miss & Precise Entry and Exit Recommendations - BỘ NỘI VỤ
Roivant Sciences Ltd. $ROIV is Tejara Capital Ltd's 10th Largest Position - MarketBeat
Bank Watch: Why Roivant Sciences Ltd. stock remains resilientJuly 2025 Reactions & Low Drawdown Momentum Ideas - moha.gov.vn
Te Ahumairangi Investment Management Ltd Increases Stock Holdings in Roivant Sciences Ltd. $ROIV - MarketBeat
SG Americas Securities LLC Has $489,000 Holdings in Roivant Sciences Ltd. $ROIV - MarketBeat
Growth Report: Why Roivant Sciences Ltd. stock is in analyst buy zoneWeekly Risk Summary & Weekly Return Optimization Alerts - BỘ NỘI VỤ
Can Roivant Sciences Ltd. stock double in next 5 years2025 Technical Overview & Fast Exit and Entry Strategy Plans - BỘ NỘI VỤ
Will Roivant Sciences Ltd. stock deliver shareholder valueQuarterly Performance Summary & Free Expert Verified Stock Movement Alerts - BỘ NỘI VỤ
Top Growth Companies With Strong Insider Ownership For November 2025 - Yahoo Finance UK
Why Roivant Sciences Ltd. stock could be next big winnerWeekly Loss Report & Weekly High Return Opportunities - BỘ NỘI VỤ
Roivant Sciences (NASDAQ:ROIV) Shares Acquired Rep. Lisa C. McClain - MarketBeat
QVT Financial LP Reduces Stake in Roivant Sciences Ltd - GuruFocus
[Form 4] Roivant Sciences Ltd. Insider Trading Activity - Stock Titan
CFO Pulik Surrenders 1,235 Of Roivant Sciences Ltd [ROIV] - TradingView
Indian-origin billionaire Vivek Ramaswamy’s 80% net worth surge is NOT all from US politics - financialexpress.com
Sunday’s Insider Moves: Major Buys at STAA, ANVS While ROIV Sees Selling By Investing.com - Investing.com Nigeria
Sunday’s Insider Moves: Major Buys at STAA, ANVS While ROIV Sees Selling - Investing.com Nigeria
Roivant Sciences Insider Sold Shares Worth $26,304,500, According to a Recent SEC Filing - marketscreener.com
Roivant Sciences Ltd. (87S.SG) Q4 FY2025 earnings call transcript - Yahoo Finance
QVT Financial LP sells Roivant Sciences (ROIV) shares worth $26.3 million - Investing.com Nigeria
Roivant Sciences director Manchester sells $26.3m in shares By Investing.com - Investing.com Nigeria
QVT Financial LP sells Roivant Sciences (ROIV) shares worth $26.3 million By Investing.com - Investing.com South Africa
Roivant Sciences director Gold sells $26.3 million in shares By Investing.com - Investing.com Nigeria
Roivant Sciences director Gold sells $26.3 million in shares - Investing.com
Roivant Sciences Ltd (ROIV) 財務データ
収益
当期純利益
現金流量
EPS
Roivant Sciences Ltd (ROIV) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Gold Daniel Allen | Director |
Nov 19 '25 |
Sale |
20.23 |
1,300,000 |
26,304,500 |
18,047,727 |
| QVT Financial LP | Director by Deputization |
Nov 19 '25 |
Sale |
20.23 |
1,300,000 |
26,304,500 |
18,047,727 |
| Ramaswamy Vivek | 10% Owner |
Nov 14 '25 |
Sale |
20.33 |
1,027,670 |
20,892,531 |
34,193,406 |
| Ramaswamy Vivek | 10% Owner |
Nov 17 '25 |
Sale |
20.51 |
539,650 |
11,068,222 |
33,653,756 |
| Ramaswamy Vivek | 10% Owner |
Nov 13 '25 |
Sale |
20.81 |
287,283 |
5,978,359 |
35,221,076 |
| Venker Eric | President & Immunovant CEO |
Nov 07 '25 |
Option Exercise |
3.85 |
200,000 |
770,000 |
1,704,959 |
| Venker Eric | President & Immunovant CEO |
Nov 07 '25 |
Sale |
20.22 |
200,000 |
4,044,000 |
1,504,959 |
0.77%
0.84%
大文字化:
|
ボリューム (24 時間):